These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20465105)

  • 1. [Care for diabetic patients with vascular disease].
    Smahelová A
    Vnitr Lek; 2010 Apr; 56(4):324-8. PubMed ID: 20465105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes mellitus in practice].
    Noelle H
    Ther Ggw; 1971 Feb; 110(2):158 passim. PubMed ID: 5100451
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antihyperglycaemic treatment and vascular diseases].
    Svacina S
    Vnitr Lek; 2010 Apr; 56(4):313-6. PubMed ID: 20465102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening and treatment of diabetic microangiopathy].
    Labbé L; Maréchaud R; Hadjadj S
    Rev Prat; 2007 Sep; 57(13):1434-43. PubMed ID: 18018542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Update diabetes mellitus and cardiovascular diseases].
    Otter W
    MMW Fortschr Med; 2012 Apr; 154(7):95-8. PubMed ID: 22558884
    [No Abstract]   [Full Text] [Related]  

  • 6. How good is the statistical evidence against oral hypoglycemic agents?
    Feinstein AR
    Adv Intern Med; 1979; 24():71-95. PubMed ID: 371369
    [No Abstract]   [Full Text] [Related]  

  • 7. [Control of diabetes and late complications].
    Chabot V; Kappeler H; Morell B
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1192-8. PubMed ID: 2237045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emergencies in diabetic patients].
    Jacot E
    Praxis (Bern 1994); 1995 Nov; 84(45):1300-3. PubMed ID: 7491457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular disease risk markers in diabetes: monitoring & intervention.
    Winters S; Jernigan V
    Nurse Pract; 2000 Jun; 25(6 Pt 1):40, 43-6, 49 passim; quiz 65-7. PubMed ID: 10884996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward achieving euglycemia in kidney transplanted and hemodialysis diabetics.
    Levitz CS; Hirsch S; Ross JM; Butt KM; Friedman EA
    Proc Clin Dial Transplant Forum; 1980; 10():248-52. PubMed ID: 7050985
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects.
    Camera A; Hopps E; Caimi G
    Minerva Endocrinol; 2007 Sep; 32(3):209-29. PubMed ID: 17912158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of compensation in diabetes mellitus in the development of diabetic microangiopathies (a review of the literature)].
    Gendeleka GF
    Vrach Delo; 1989 Aug; (8):54-8. PubMed ID: 2686158
    [No Abstract]   [Full Text] [Related]  

  • 14. Perioperative care of diabetic patient.
    Scherpereel P
    Minerva Anestesiol; 2001 Apr; 67(4):258-62. PubMed ID: 11376520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) study.
    Odawara M; Kadowaki T; Naito Y
    J Diabetes Complications; 2015; 29(1):127-33. PubMed ID: 25449981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Some aspects of pathogenetic therapy of diabetic angiopathies].
    Efimov AS; Skrobonskaia NA; Karabun PM; Danilova AI; Zubkova ST; Naumenko VG; Mankovskiĭ BN; Melńik IM; Malik A; Tkachuk IuV
    Klin Med (Mosk); 1994; 72(1):20-3. PubMed ID: 8196316
    [No Abstract]   [Full Text] [Related]  

  • 17. [Conservative treatment of diabetic microangiopathy and macroangiopathy].
    Smahelová A
    Cas Lek Cesk; 2009; 148(2):72-5, 77. PubMed ID: 19637441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetes-specific complications in prediabetes].
    Putz Z; Kempler P; Jermendy G
    Orv Hetil; 2009 Nov; 150(47):2139-45. PubMed ID: 19910279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress of the research on diabetes treatment and changes of the ways of the treatment].
    Akanuma Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():11-7. PubMed ID: 9434436
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.